Increased microRNA-34c abundance in Alzheimer's disease circulating blood plasma

Frontiers in Molecular Neuroscience

Volumn 7, Issue FEB, 2014, Pages

  Bhatnagar, Shephali ^a   Chertkow, Howard ^b,c,d,e   Schipper, Hyman M ^b,d,e   Yuan, Zongfei ^a   Shetty, Vikranth ^a   Jenkins, Samantha ^a   Jones, Timothy ^a   Wang, Eugenia ^a  

^a Advanced Genomic Technology LLC   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d MCGILL UNIVERSITY   (Canada)

^e MCGILL UNIVERSITY   (Canada)

Author keywords

miR 34a; miR 34c; Peripheral blood mononuclear cells (PBMC); Plasma microRNA

Indexed keywords

MICRORNA; MICRORNA 34A; MICRORNA 34C; ONECUT2 PROTEIN; PEPTIDES AND PROTEINS; PRESENILIN 1; PROTEIN BCL 2; SIRTUIN 1; UNCLASSIFIED DRUG;

ACCURACY; ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD LEVEL; CELL ISOLATION; CELL SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DEFENSE MECHANISM; DIAGNOSTIC TEST ACCURACY STUDY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MINI MENTAL STATE EXAMINATION; PERIPHERAL BLOOD MONONUCLEAR CELL; QUALITY CONTROL; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; VERY ELDERLY; WESTERN BLOTTING;

EID: 84893523143     PISSN: 16625099     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnmol.2014.00002     Document Type: Article

References (45)

1. Bates, D. J., Li, N., Liang, R., Sarojini, H., An, J., Masternak, M. M., et al. (2010). MicroRNA regulation in Ames dwarf mouse liver may contribute to delayed aging. Aging Cell 9, 1-18. doi: 10.1111/j.1474-9726.2009.00529.x
2. Clotman, F., Jacquemin, P., Plumb-Rudewiez, N., Pierreux, C. E., Van der Smissen, P., Dietz, H. C., et al. (2005). Control of liver cell fate decision by a gradient of TGFβ signaling modulated by Onecut transcriptional factors. Genes Dev. 19, 1849-1854. doi: 10.1101/gad.340305
3. De Smaelea, E., Ferrettia, E., and Gulinoa, A. (2010). MicroRNAs as biomarkers for CNS cancer and other disorders. Brain Res. 1338, 100-111. doi: 10.1016/j.brainres.2010.03.103
4. Etheridge, A., Lee, I., Hood, L., Galas, D., and Wang, K. (2011). Extracelluar microRNA: a new source of biomarkers. Mutat. Res. 717, 85-90. doi: 10.1016/j.mrfmmm.2011.03.004
5. Fawcett, T. (2006). An introduction to ROC analysis. Pattern Recognit. Lett. 27, 861-874. doi: 10.1016/j.patrec.2005.10.010
6. Folstein, M., Folstein, S., and McHugh, S. (1975). Mini-Mental State: a practical method for grading the cognitive status of patients for the clinician. J. Psychiatr. Res. 12, 189-198. doi: 10.1016/0022-3956(75)90026-6
7. Gaughwin, P. M., Ciesla, M., Lahiri, N., Tabrizi, S. J., Brundin, P., and Björkqvist, M. (2011). Hsa-miR-34b is a plasma-stable microRNA that is elevated in pre-manifest Huntington's disease. Hum. Mol. Genet. 20, 2225-2237. doi: 10.1093/hmg/ddr111
8. Geekiyanage, H., Jicha, G. A., Nelson, P. T., and Chan, C. (2012). Blood serum miRNA: non-invasive biomarkers for Alzheimer's disease. Exp. Neurol. 235, 491-496. doi: 10.1016/j.expneurol.2011.11.026
9. Goodall, E. E., Heath, P. R., Bandmann, O., Kirby, J., and Shaw, P. J. (2013). Neuronal dark matter: the emerging role of microRNA in neurodegeneration. Front. Cell. Neurosci. 7:178. doi: 10.3389/fncel.2013.00178
10. He, L., He, X. Y., Lowe, S. W., and Hannon, G. J. (2007). microRNAs join the p53 network-another piece in the tumour-suppression puzzle. Nat. Rev. Cancer 7, 819-882. doi: 10.1038/nrc2232
11. Khanna, A., Muthusamy, S., Liang, R., Sarojini, H., and Wang, E. (2011). Gain of survival signaling by down-regulation of three key miRNAs in brain of calorie-restricted mice. Aging 3, 223-236.
12. Kirschner, M. B., Edelman, J. J. B., Kao, S. C.-H., Vallely, M. P., van Zandwijk, N., and Reid, G. (2013). The impact of hemolysis on cell-free microRNA biomarkers. Front. Genet. 4:94. doi: 10.3389/fgene.2013.00094
13. Kirschner, M. B., Kao, S. C., Edelman, J. J., Armstrong, N. J., Vallely, M. P., van Zandwijk, N., et al. (2011). Haemolysis during sample preparation alters microRNA content of plasma. PLoS ONE 6:e24145. doi: 10.1371/journal.pone.0024145
14. Kroh, E. M., Parkin, R. K., Mitchell, P. S., and Tewari, M. (2010). Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods 50, 298-301. doi: 10.1016/j.ymeth.2010.01.032
15. Li, G., and Chung, W. Y. (2013). Detection of driver drowsiness using wavelet analysis of heart rate variability and a support vector machine classifier. Sensors 13, 16494-16511. doi: 10.3390/s131216494
16. Li, X., Khanna, A., Li, N., and Wang, E. (2011a). Circulatory miR-34a as an RNA-based, noninvasive biomarker for brain aging. Aging 3, 985-1002.
17. Li, N., Bates, D. J., An, J., and Wang, E. (2011b). Up-regulation of key microRNAs and the inverse down-regulation of their potential target genes of oxidative phosphorylation during aging in mouse brains. Neurobiol. Aging 32, 944-955. doi: 10.1016/j.neurobiolaging.2009.04.020
18. Li, N., Muthusamy, S., Liang, R., Sarojini, H., and Wang, E. (2011c). Increased expression of miR-34a and miR-93 in rat liver during aging and their impact on the expression of Mgst1 and Sirt1. Mech. Ageing Dev. 132, 75-85. doi: 10.1016/j.mad.2010.12.004
19. Liang, R., Bates, D. J., and Wang, E. (2009). Epigenetic control of microRNA expression and aging. Curr. Genomics 10, 184-193. doi: 10.2174/138920209788185225
20. -ΔΔ CT method. Methods 25, 402-408. doi: 10.1006/meth.2001.1262
21. Maes, O. C., Chertkow, H. M., Wang, E., and Schipper, H. M. (2010). MicroRNA: Implications for Alzheimer's disease and other human CNS disorders. Curr. Genomics 10, 154-168. doi: 10.2174/138920209788185252
22. McDonald, J. S., Milosevic, D., Reddi, H. V., Grebe, S. K., and Algeciras-Schimnich, A. (2011). Analysis of circulating microRNA: preanalytical and analytical challenges. Clin. Chem. 57, 833-840. doi: 10.1373/clinchem.2010.157198
23. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., and Stadlan, E. M. (1984). Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34, 939-944. doi: 10.1212/WNL.34.7.939
24. McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R. Jr, Kawas, C. H., et al. (2011). The diagnosis of dementia due to Alzheimer's disease: recommendation from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 263-269. doi: 10.1016/j.jalz.2011.03.005
25. Müller, M., Kuiperij, H. B., Claassen, J. A., Küsters, B., and Verbeek, M. M. (2014). MicroRNAs in Alzheimer's disease: differential expression in hippocampus and cell-free cerebrospinal fluid. Neurobiol. Aging 35, 152-158. doi: 10.1016/j.neurobiolaging.2013.07.005
26. Nasreddine, Z. S., Phillips, N. A., Bédirian, V., Charbonneau, S., Whitehead, V., Collin, I., et al. (2005). The Montréal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J. Am. Geriatr. Soc. 53, 695-699. doi: 10.1111/j.1532-5415.2005.53221.x
27. O'Bryant, S. E., Xiao, G., Barber, R., Huebinger, R., Wilhelmsen, K., Edwards, M., et al. (2011). A blood based screening tool for Alzheimer's disease that spans serum and plasma: Findings from TARC and ADNI. PLoS ONE 6:e28092. doi: 10.1371/journal.pone.0028092
28. Pendyala, G., Trauger, S. A., Siuzdak, G., and Fox, H. S. (2010). Quantitative plasma proteomic profiling identifies the vitamin E binding protein afamin as a potential pathogenic factor in SIV induced CNS disease. J. Proteome Res. 9, 352-358. doi: 10.1021/pr900685u
29. Rong, H., Liu, T. B., Yang, K. J., Yang, H. C., Wu, D. H., Liao, C. P., et al. (2011). MicroRNA-134 plasma levels before and after treatment for bipolar mania. J. Psychiatr. Res. 45, 92-95. doi: 10.1016/j.jpsychires.2010.04.028
30. Schipper, H. M., Maes, O. C., Chertkow, H. M., and Wang, E. (2007). MicroRNA expression in Alzheimer blood mononuclear cells. Gene Regul. Syst. Bio. 1, 263-274.
31. Schmand, B., Jonker, C., Hooijer, C., and Lindeboom, J. (1996). Subjective memory complaints may announce dementia. Neurology 46, 121-125. doi: 10.1212/WNL.46.1.121
32. Sharp, E., and Gatz, M. (2011). The relationship between education and dementia: an updated systematic review. Alzheimer Dis. Assoc. Disord. 25, 289-304. doi: 10.1097/WAD.0b013e318211c83c
33. Sheinerman, K. S., Tsivinsky, V. G., Crawford, F., Mullan, M. J., Abdullah, L., and Umansky, S. R. (2012). Plasma microRNA biomarkers for detection of mild cognitive impairment. Aging 4, 590-605.
34. Sheinerman, K. S., and Umansky, S. R. (2013). Circulating cell-free microRNA as biomarkers for screening, diagnosis, and monitoring of neurodegenerative disease and other neurologic pathologies. Front. Cell. Neurosci. 7:150. doi: 10.3389/fncel.2013.00150
35. Shi, W., Du, J., Qi, Y., Liang, G., Wang, T., Li, S., et al. (2012). Aberrant expression of serum miRNA in schizophrenia. J. Psychiatr. Res 46, 198-204. doi: 10.1016/j.jpsychires.2011.09.010
36. Smalheiser, N. R. (2007). Exosomal transfer of proteins and RNAs at synapses in the nervous system. Biol. Direct 2:35. doi: 10.1186/1745-6150-2-35
37. Suarez-Gomez, M., Alejandre-Duran, E., and Ruiz-Rubio, M. (2011). MicroRNAs in bipolar disorder: diagnostic and therapeutic applications. Rev. Neurol. 53, 91-98.
38. Taylor, R. (1990). Interpretation of the correlation coefficient: a basic review. JDMS 1, 35-39.
39. Toledo, J. B., Da, X., Bhatt, P., Wolk, D. A., Arnold, S. E., Shaw, L. M., et al. (2013). Relationship between plasma analytes and SPARE-AD defined brain atrophy patterns in ADNI. PLoS ONE 8:e55531. doi: 10.1371/journal.pone.0055531
40. Toledo, J. B., Vanderstichele, H., Figurski, M., Aisen, P. S., Petersen, R. C., Weiner, M. W., et al. (2011). Factors affecting Aβ plasma levels and their utility as biomarkers in ADNI. Acta Neuropathol. 122, 401-413. doi: 10.1007/s00401-011-0861-8
41. Wang, X., Liu, P., Zhu, H., Xu, Y., Ma, C., Dai, X., et al. (2009). miR-34a, a microRNA up-regulated in a double transgenic mouse model of Alzheimer's disease, inhibits Bcl2 translation. Brain Res. Bull. 80, 268-273. doi: 10.1016/j.brainresbull.2009.08.006
42. Wechsler, D. (2008). Wechsler Memory Scale, 4th Edn. San Antonio, TX: Pearson.
43. Yamakuchi, M., Ferlito, M., and Lowenstein, C. J. (2008). miR-34a repression of SIRT1 regulates apoptosis. Proc. Natl. Acad. Sci. U.S.A. 105, 13421-13426. doi: 10.1073/pnas.0801613105
44. Zovoilis, A., Agbemenyah, H. Y., Agis-Balboa, R. C., Stilling, R. M., Edbauer, D., Rao, P., et al. (2011). microRNA-34c is a novel target to treat dementias. EMBO J. 30, 4299-4308. doi: 10.1038/emboj.2011.327
45. Zweig, M. H., and Campbell, G. (1993). Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin. Chem. 39, 561-577.